The future of mRNA research in cancer is promising, with ongoing studies aimed at improving mRNA delivery systems, developing more effective mRNA vaccines, and identifying new mRNA biomarkers. Personalized medicine approaches that tailor mRNA-based therapies to individual patients' genetic profiles are also being explored. Continued research and clinical trials will be crucial for translating these advances into standard cancer care.
